S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Best Bear Market Funds: Top 3 Investment Options to Consider
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
Merck, Cintas rise; GameStop, MiMedx fall, Wednesday, 3/27/2024
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Best Bear Market Funds: Top 3 Investment Options to Consider
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
Merck, Cintas rise; GameStop, MiMedx fall, Wednesday, 3/27/2024
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Best Bear Market Funds: Top 3 Investment Options to Consider
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
Merck, Cintas rise; GameStop, MiMedx fall, Wednesday, 3/27/2024
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Best Bear Market Funds: Top 3 Investment Options to Consider
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
Merck, Cintas rise; GameStop, MiMedx fall, Wednesday, 3/27/2024
LON:SBTX

SkinBioTherapeutics (SBTX) Share Price, News & Analysis

GBX 13.25
+1.13 (+9.28%)
(As of 01:06 PM ET)
Today's Range
12
14.20
50-Day Range
7
16.50
52-Week Range
7
29.50
Volume
1.93 million shs
Average Volume
687,720 shs
Market Capitalization
£25.55 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
SBTX stock logo

About SkinBioTherapeutics Stock (LON:SBTX)

SkinBioTherapeutics plc, a life science company, engages in identification and development of technology that harnesses the human microbiome to improve health in the United Kingdom, the United States, and Europe. It develops SkinBiotix technology that promotes skin health by harnessing the beneficial properties of probiotic bacteria and the active components; and AxisBiotix technology that focuses on the gut-skin relationship and is designed to alleviate the symptoms associated with psoriasis. The company has an agreement with Croda Plc; and operates two research programmes with the University of Manchester, an oral programme and an inflammation study. It serves cosmetic skincare, food supplements, medical skin care, infection control, and pharmaceutical skincare markets. The company was formerly known as Skinbiotix Ltd and changed its name to SkinBioTherapeutics plc in December 2016. SkinBioTherapeutics plc was incorporated in 2015 and is based in Newcastle upon Tyne, the United Kingdom.

SBTX Stock Price History

SBTX Stock News Headlines

Top Project Outperforms BTC in 2023…
According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.
SkinBioTherapeutics bags £3m at a modest discount
SkinBioTherapeutics to Raise at Least $3.7 Mln
Fiverr International Ltd DRC (F2VR34)
SBTX.L - SkinBioTherapeutics Plc
Top Project Outperforms BTC in 2023…
According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.
SkinBioTherapeutics Reports First Half 2023 Earnings
SkinBioTherapeutics to Raise a Minimum of GBP2.5 Mln
What It's Like Inside a Burning Drift Car
SkinBioTherapeutics CFO to Step Down
See More Headlines
Receive SBTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SkinBioTherapeutics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/03/2020
Today
3/27/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
11
Year Founded
N/A

Profitability

Net Income
£-2,840,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£21,949.00
Cash Flow
GBX 1.35 per share
Book Value
GBX 1 per share

Miscellaneous

Free Float
N/A
Market Cap
£23.38 million
Optionable
Not Optionable
Beta
1.52
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Stuart John Ashman (Age 58)
    CEO & Executive Director
    Comp: $371.1k
  • Mr. Manprit Singh Randhawa (Age 41)
    CFO, Secretary & Director
    Comp: $261.48k
  • Dr. Catherine O'Neill
    Chief Scientific Officer & Member of Scientific Advisory Board
  • Laura Bey
    Head of Formulations
  • Ms. Melissa Greenwell
    Group Financial Controller

SBTX Stock Analysis - Frequently Asked Questions

How have SBTX shares performed in 2024?

SkinBioTherapeutics' stock was trading at GBX 15.25 at the beginning of the year. Since then, SBTX stock has decreased by 13.1% and is now trading at GBX 13.25.
View the best growth stocks for 2024 here
.

How were SkinBioTherapeutics' earnings last quarter?

SkinBioTherapeutics plc (LON:SBTX) released its quarterly earnings results on Tuesday, March, 3rd. The company reported ($0.64) earnings per share (EPS) for the quarter.

What other stocks do shareholders of SkinBioTherapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other SkinBioTherapeutics investors own include Avacta Group (AVCT), Inspired (INSE), OptiBiotix Health (OPTI), Lb-shell (LBP), Anglo African Oil & Gas (AAOG), Big Sofa Technologies Group (BST), Concepta PLC (CPT.L) (CPT), Fresnillo (FRES) and Shield Therapeutics (STX).

How do I buy shares of SkinBioTherapeutics?

Shares of SBTX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:SBTX) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners